Barrington James

Description

Im working with a major global biotech with a long-standing rare-disease portfolio is searching for a Director of Market Access & Channel Strategy to take ownership of U.S. access strategy across a portfolio of high-impact therapies. The incoming Director will step directly into a high-visibility, analytically intensive role that shapes pricing, distribution, and payer strategy for both existing and soon-to-launch products.

Why this role stands out

This is a unique opportunity to make your mark quickly:

• You'll work closely with a new, change-driven SVP who recently joined from the global business and is highly open to fresh thinking.
• You'll partner directly with a senior leader overseeing all U.S. rare disease market access, plus two additional therapeutic groups and the analytics team, creating a strong platform for influence.
• You'll shape strategy for an established inline portfolio in the immunology/rare disease space and guide multiple new launches, including an upcoming combination treatment and several future products and indications.

What You Will Lead

You'll own the core market access levers that determine how rare-disease therapies reach patients in the U.S.:

• Setting pricing strategy for inline and pipeline assets
• Designing distribution and channel strategy across key U.S. pathways
• Leading contracting strategy in partnership with specialized pull-through teams
• Developing payer-focused value messaging and evidence needs
• Stress-testing existing approaches and identifying where the business needs to evolve
• Supporting brand planning, commercial readiness, and launch execution
• Providing market access input into pipeline development and future assets

This is a role with plenty of structural support, including contracting teams, analytics, and commercial excellence, but the strategic direction will be yours to define.

What They're Looking For

The Team Wants Someone Who Has

• U.S. market access experience (required)
• Experience in rare disease (strongly preferred)
• Pricing strategy
• Distribution strategy
• Contracting strategy
• Channel strategy
• Both inline and pipeline/launch experience
• A track record of driving strategic change, challenging assumptions, and shaping strategy, not just executing it
• Global experience is a nice-to-have, not required

Why now?

• The rare-disease business is entering a phase of significant expansion, with new launches, new indications, and new leadership ready to rethink how access strategy is built. This role will sit at the center of that change.
• If you're ready to step into a role that blends strategy, analysis, influence, and meaningful patient impact, this is an opportunity to genuinely shape the future of a growing U.S. portfolio.

Compensation & Practicalities

• Director level
• Salary range: $174,500-$274,230
• Internal equity typically $225K-$240K, depending on experience
• Bonus: 26%
• LTI: ~$70,000
• Relocation: Yes
• Visa sponsorship: Not at this time (due to urgency of start date)
• Full suite of competitive U.S. benefits